Analyst Ratings for Arena Pharma (ARNA)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/28/2011 | Piper Jaffray | N/A | Upgrade | Overweight (N/A) |
3.00 (N/A) |
1.27 (2.05) |
61.42% | Details |
| 9/8/2011 | BMO Capital | N/A | New Coverage | Market Perform (N/A) |
1.00 (N/A) |
1.30 (2.05) |
57.69% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
